programs
-
KAIST Develops CamBio - a New Biotemplating Method
- Professor Jae-Byum Chang and Professor Yeon Sik Jung’s joint research team of the Department of Materials Science and Engineering developed a highly tunable bio-templating method “CamBio” that makes use of intracellular protein structures
- Substrate performance improvement of up to 230% demonstrated via surface-enhanced Raman spectroscopy (SERS)
- Expected to have price competitiveness over bio-templating method as it expands the range of biological samples
- Expected to expand the range of application of nanostructure synthesis technology by utilizing various biological structures
< Photo 1. (From left) Professor Yeon Sik Jung, Ph.D. candidate Dae-Hyeon Song, Professor Jae-Byum Chang, and (from top right) Dr. Chang Woo Song and Dr. Seunghee H. Cho of the Department of Materials Science and Engineering >
Biological structures have complex characteristics that are difficult to replicate artificially, but biotemplating methods* that directly utilize these biological structures have been used in various fields of application. The KAIST research team succeeded in utilizing previously unusable biological structures and expanding the areas in which biotemplate methods can be applied.
*Biotemplating: A method of using biotemplates as a mold to create functional structural materials, utilizing the functions of these biological structures, from viruses to the tissues and organs that make up our bodies
KAIST (President Kwang Hyung Lee) announced on the 10th that a joint research team of Professors Jae-Byum Chang and Professor Yeon Sik Jung of the Department of Materials Science and Engineering developed a biotemplating method that utilizes specific intracellular proteins in biological samples and has high tunability.
Existing biotemplate methods mainly utilize only the external surface of biological samples or have limitations in utilizing the structure-function correlation of various biological structures due to limited dimensions and sample sizes, making it difficult to create functional nanostructures.
To solve this problem, the research team studied a way to utilize various biological structures within the cells while retaining high tunability.
< Figure 1. CamBio utilizing microtubules, a intracellular protein structure. The silver nanoparticle chains synthesized along the microtubules that span the entire cell interior can be observed through an electron microscope, and it is shown that this can be used as a successful SERS substrate. >
As a result of the research, the team developed the “Conversion to advanced materials via labeled Biostructure”, shortened as “CamBio”, which enables the selective synthesis of nanostructures with various characteristics and sizes from specific protein structures composed of diverse proteins within biological specimens.
The CamBio method secures high tunability of functional nanostructures that can be manufactured from biological samples by merging various manufacturing and biological technologies.
Through the technology of repeatedly attaching antibodies, arranging cells in a certain shape, and thinly slicing tissue, the functional nanostructures made with CamBio showed improved performance on the surface-enhanced Raman spectroscopy (SERS)* substrate used for material detection.
*Surface-enhanced Raman spectroscopy (SERS): A technology that can detect very small amounts of substances using light, based on the principle that specific substances react to light and amplifies signals on surfaces of metals such as gold or silver.
The research team found that the nanoparticle chains made using the intracellular protein structures through the process of repeated labeling with antibodies allowed easier control, and improved SERS performance by up to 230%.
In addition, the research team expanded from utilizing the structures inside cells to obtaining samples of muscle tissues inside meat using a cryostat and successfully producing a substrate with periodic bands made of metal particles by performing the CamBio process. This method of producing a substrate not only allows large-scale production using biological samples, but also shows that it is a cost-effective method.
< Figure 2. A method for securing tunability using CamBio at the cell level. Examples of controlling characteristics by integrating iterative labeling and cell pattering techniques with CamBio are shown. >
The CamBio developed by the research team is expected to be used as a way to solve problems faced by various research fields as it is to expand the range of bio-samples that can be produced for various usage.
The first author, Dae-Hyeon Song, a Ph.D. candidate of KAIST Department of Materials Science and Engineering said, “Through CamBio, we have comprehensively accumulated biotemplating methods that can utilize more diverse protein structures,” and “If combined with the state-of-the-art biological technologies such as gene editing and 3D bioprinting and new material synthesis technologies, biostructures can be utilized in various fields of application.”
< Figure 3. A method for securing tunability using CamBio at the tissue level. In order to utilize proteins inside muscle tissue, the frozen tissue sectioning technology is combined, and through this, a substrate with a periodic nanoparticle band pattern is successfully produced, and it is shown that large-area acquisition of samples and price competitiveness can be achieved. >
This study, in which the Ph.D. candidate Dae-Hyeon Song along with Dr. Chang Woo Song, and Dr. Seunghee H. Cho of the same department participated as the first authors, was published online in the international academic journal, Advanced Science, on November 13th, 2024.
(Paper title: Highly Tunable, Nanomaterial-Functionalized Structural Templating of Intracellular Protein Structures Within Biological Species) https://doi.org/10.1002/advs.202406492
This study was conducted with a combination of support from various programs including the National Convergence Research of Scientific Challenges (National Research Foundation of Korea (NRF) 2024), Engineering Reseach Center (ERC) (Wearable Platform Materials Technology Center, NRF 2023), ERC (Global Bio-integrated Materials Center, NRF 2024), and the National Advanced Program for Biological Research Resources (Bioimaging Data Curation Center, NRF 2024) funded by Ministry of Science and ICT.
2025.01.10 View 2941 -
KAIST to Collaborate with AT&C to Take Dominance over Dementia
< Photo 1. (From left) KAIST Dean of the College of Natural Sciences Daesoo Kim, KAIST President Kwang Hyung Lee, AT&C Chairman Ki Tae Lee, AT&C CEO Jong-won Lee >
KAIST (President Kwang Hyung Lee) announced on January 9th that it signed a memorandum of understanding for a comprehensive mutual cooperation with AT&C (CEO Jong-won Lee) at its Seoul Dogok Campus to expand research investment and industry-academia cooperation in preparation for the future cutting-edge digital bio era.
Senile dementia is a rapidly increasing brain disease that affects 10% of the elderly population aged 65 and older, and approximately 38% of those aged 85 and older suffer from dementia. Alzheimer's disease is the most common dementia in the elderly and its prevalence has been increasing rapidly in the population of over 40 years of age. However, an effective treatment is yet to be found.
The Korean government is investing a total of KRW 1.1 trillion in dementia R&D projects from 2020 to 2029, with the goal of reducing the rate of increase of dementia patients by 50%. Since it takes a lot of time and money to develop effective and affordable medicinal dementia treatments, it is urgent to work on the development of digital treatments for dementia that can be applied more quickly.
AT&C, a digital healthcare company, has already received approval from the Ministry of Food and Drug Safety (MFDS) for its device for antidepressant treatment based on transcranial magnetic stimulation (TMS) using magnetic fields and is selling it domestically and internationally. In addition, it has developed the first Alzheimer's dementia treatment device in Korea and received MFDS approval for clinical trials. After passing phase 1 to evaluate safety and phase 2 to test efficacy on some patients, it is currently conducting phase 3 clinical trials to test efficacy on a larger group of patients.
This dementia treatment device is equipped with a system that combines non-invasive electronic stimulations (TMS electromagnetic stimulator) and digital therapeutic prescription (cognitive learning programs) to provide precise, automated treatment by applying AI image analysis and robotics technology.
Through this agreement, KAIST and AT&C have agreed to cooperate with each other in the development of innovative digital treatment equipment for brain diseases. Through research collaboration with KAIST, AT&C will be able to develop technology that can be widely applied to Parkinson's disease, stroke, mild cognitive impairment, sleep disorders, etc., and will develop portable equipment that can improve brain function and prevent dementia at home by utilizing KAIST's wearable technology.
To this end, AT&C plans to establish a digital healthcare research center at KAIST by supporting research personnel and research expenses worth approximately 3 billion won with the goal of developing cutting-edge digital equipment within 3 years.
The digital equipment market is expected to grow at a compounded annual growth rate of 22.1% from 2023 to 2033, reaching a market size of $1.9209 trillion by 2033.
< Photo 2. (From left) Dean of the KAIST College of Natural Sciences Daesoo Kim, Professor Young-joon Lee, Professor Minee Choi of the KAIST Department of Brain and Cognitive Sciences, KAIST President Kwang Hyung Lee, Chairman Ki Tae Lee, CEO Jong-won Lee, and Headquarters Director Ki-yong Na of AT&C >
CEO Jong-won Lee said, “AT&C is playing a leading role in the treatment of Alzheimer’s disease using TMS (transcranial magnetic stimulation) technology. Through this agreement with KAIST, we will do our best to create a new paradigm for brain disease treatment and become a platform company that can lead future medical devices and medical technology.”
Former Samsung Electronics Vice Chairman Ki Tae Lee, a strong supporter of this R&D project, said, “Through this agreement with KAIST, we plan to prepare for a new future by combining the technologies AT&C has developed so far with KAIST’s innovative and differentiated technologies.”
KAIST President Kwang Hyung Lee emphasized, “Through this collaboration, KAIST expects to build a world-class digital therapeutics infrastructure for treating brain diseases and contribute greatly to further strengthening Korea’s competitiveness in the biomedical field.”
The signing ceremony was attended by KAIST President Kwang Hyung Lee, the Dean of KAIST College of Natural Sciences Daesoo Kim, AT&C CEO Lee Jong-won, and the current Chairman of AT&C, Ki Tae Lee, former Vice Chairman of Samsung Electronics.
2025.01.09 View 2837 -
KAIST Opens Newly Expanded Center for Contemplative Research in Collaboration with Brain and Cognitive Sciences Department
KAIST (represented by President Kwang Hyung Lee) announced on January 2nd that it would hold an opening ceremony for the expanded KAIST Center for Contemplative Research (Director Wan Doo Kim) at the Creativity Learning Building on its Daejeon campus on January 3 (Friday).
Established in 2018 with the mission of "integrating meditation and science for the happiness and prosperity of humanity," the KAIST Center for Contemplative Research has been expanding its scope of research into the neuroscience of meditation and training empathetic educators who will lead the field of meditation science in collaboration with the Brain and Cognitive Sciences Department, which was established in 2022.
Supported by the Plato Academy Foundation and with funding from SK Discovery for the facility’s expansion, the center now occupies an extended space on the 5th floor of the Creativity Learning Center. The new facilities include: ▲ Advanced Research Equipment ▲ Meditation Science Laboratories ▲ VR/XR-Based Meditation Experience Rooms ▲ A Large Digital Art Meditation Hall ▲ Personal Meditation Halls.
Particularly, the center plans to conduct next-generation meditation research using cutting-edge technologies such as: ▲ Brain-Computer Interface Technology ▲ Meditation Wearable Devices ▲ Metaverse-Based Meditation Environments.
The opening ceremony, scheduled for the morning of January 3 (Friday), was attended by key figures, including Plato Academy Foundation Chairman Chang-Won Choi, MindLab CEO Professor Seong-Taek Cho, Bosung Group Vice President Byung-Chul Lee, and KAIST President Kwang Hyung Lee.
The event began with a national moment of silence to honor the victims of the recent Jeju Air passenger accident. It included a progress report by the center director, a lecture by Professor Jaeseung Jeong, panel discussions, and more.
Following a tour of the expanded facilities, the center hosted a 20-minute hands-on meditation science session using *Looxid Labs EEG devices for the first 50 participants.
*Looxid Labs EEG Device: A real-time brainwave measurement device developed by KAIST startup Looxid Labs that enables users to experience efficient and AI-powered data-driven meditation science practice (Looxid Labs website: https://looxidlabs.com/).
During the ceremony, Director of the Center for Contemplative Research Wan Doo Kim presented on "The Mission, Vision, and Future of the KAIST Center for Contemplative Research." Yujin Lee, a combined master’s and doctoral researcher from the Brain and Cognitive Sciences Department, shared insights on "The Latest Trends in Meditation Science Research."
A panel discussion and Q&A session on "The Convergence of Meditation and Brain and Cognitive Sciences" followed featuring Professors Jaeseung Jeong, HyungDong Park (Brain and Cognitive Sciences), and Jiyoung Park (Digital Humanities and Social Sciences).
Director Wan Doo Kim commented, “With this expanded opening, we aim to offer advanced meditation programs integrating brain and cognitive sciences and cutting-edge technology not only to KAIST members but also to the general public interested in meditation. We will continue to dedicate ourselves to interdisciplinary research between meditation and science.”
2025.01.03 View 2166 -
KAIST Office of Global Initiative Hosts 2024 Global Startup Internship Seminar
< Photo of ImpriMed CEO Sungwon Lim’s lecture >
The Office of Global Initiative at KAIST successfully hosted the 2024 Global Startup Internship Seminar (GSIS) from Wednesday, November 20, to Friday, November 22.
Now in its third year, following the 2022 Global Startup Internship Fair, the GSIS aims to introduce KAIST students to internship opportunities at U.S.-based startups and encourage participation in global internship programs, particularly for students with entrepreneurial aspirations. This year’s seminar featured notable startups including ImpriMed, a precision medical AI company; Klleon, an AI culture tech firm; and Bear Robotics, renowned for its autonomous serving robots. Approximately 80 KAIST students attended the event through prior registration.
A key highlight of this year’s seminar was the participation of the CEOs from Bear Robotics and ImpriMed, two prominent Silicon Valley startups. Both CEOs, who had previously participated in the 2024 Global Entrepreneurship Summer School (GESS) last June, offered insights into their companies, provided one-on-one career counseling sessions, and discussed the concept of global entrepreneurship with students interested in U.S. startup internships.
In addition to company presentations, the seminar offered practical workshops on resume and email writing tailored for U.S. internships, testimonials from current KAIST students and alumni who interned at Silicon Valley startups, and a J1 Visa Information Session, all aimed at preparing students for internships in the United States.
So Young Kim, Vice President of the International Office and Director of the Office of Global Initiative, expressed her hopes for the event, stating, “through this event, KAIST students will be inspired by the global entrepreneurial spirit of mentors who have started businesses abroad, and that it will help further spread a culture of challenging adversity and overcoming the risks of failure.” She further added that KAIST is committed to continuously developing programs that cultivate a global entrepreneurial mindset among its students.
The 2024 Global Startup Internship Seminar successfully concluded, providing KAIST students with vision and opportunities in global entrepreneurship.
2024.11.25 View 1736 -
KAIST ISSS Research Session Captivates 150↑ International Scholars, Achieve Major Success
< Photo. Scholars gatheres for NRF Information Session at Chung Keun Mo Hall >
KAIST’s International Office, headed by Vice President Soyoung Kim, successfully organized the ‘NRF Information Session for International Scholars’ on September 11, 2024, in collaboration with the National Research Foundation of Korea (NRF).
The event was held at KAIST’s main campus to enourage the international scholar’s active participation in research projects and support their establishment of stable research environment and integration into Korea’s academic community by introducing NRF’s key research programs.
Divided into two main segments – science and engineering, and humanities and social sciences – the session attracted approximately 150 international faculty and researchers from 23 universities across the nation.
The event commenced with a keynote address by Vice President Soyoung Kim, followed by a presentation from Dr. Seol Min of the National Research Foundation, who highlighted basic research initiatives in the science and technology sector. Subsequently, Professor Daniel Martin from the Digital Humanities and Social Sciences Department and Professor Thomas Steinberger from the Department of Business and Technology Management presented practical research project support case studies, sharing invaluable insights gained from their domestic research experiences.
Following the information session, participants engaged in a networking event, where researchers involved in major R&D projects exchanged insights and discussed their ongoing research initiatives.
An international professor remarked, “My understanding of NRF’s research programs for international researchers has broadened considerably. I am now more inclined to actively participate in projects organized by NRF in the future.”
Vice President Kim expressed her aspiration that the event would address the challenges faced by researchers and offer essential support to those engaged in research projects. “We will stay attuned to the needs of the research community and work towards creating a more supportive research environment,” said the VP.
Meanwhile, KAIST hosts a distinguished faculty comprising 134 professors from 22 countries and 71 researchers representing 23 nations, all contributing to groundbreaking academic achievements. Additionally, KAIST is home to over 1,000 international students from more than 100 countries, actively pursuing their studies. This diverse composition of global talent reinforces KAIST's position as a leading international hub for research and education.
2024.09.13 View 3530 -
KAIST and NYU set out to Install Korea's First Joint Degree Program in AI
< (From left) New York University President Linda Mills and President Kwang-Hyung Lee >
KAIST (President Kwang-Hyung Lee) and New York University (NYU, President Linda G. Mills) signed an MOU in the afternoon of the 9th to introduce a graduate program for a joint degree in the field of artificial intelligence.
This agreement was promoted based on the consensus between the two universities that strengthening capabilities in the field of AI and fostering global talent are essential elements that can lead to great development in the entire future society beyond simple technical education.
The two universities have been operating joint research groups in various industrial fields related to AI and convergence with it, and based on this agreement, they plan to establish an operating committee within this year to design a joint degree program for graduate school courses related to artificial intelligence.
A KAIST official said, “If the joint degree program in AI is implemented, it is expected to be an unprecedented innovative experiment in which KAIST and NYU join forces to create ‘a single AI degree.’
The committee will consist of an equal number of faculty members from both schools, and will discuss the overall strategic planning of the joint degree program, including ▴curriculum structure and course composition ▴course completion roadmap ▴calculation of faculty and student population ▴calculation of budget size ▴calculation of operating facility size and details ▴legal matters regarding certification. In addition, the development of a new logo symbolizing the joint degree of KAIST and NYU in AI will also be carried out.
The two schools expect that the joint degree program being promoted this time will contribute to advancing education and research capabilities in the field of artificial intelligence, jointly discovering and fostering talent in related fields that are currently lacking worldwide, and will become an exemplary case of global education and research cooperation.
The faculty members of both schools, who possess excellent capabilities, will provide innovative and creative education in the field of artificial intelligence. Students will receive support to gain top-level research experience by participating in various international joint research projects promoted by the faculty members of both schools. Through this, the core of this joint degree program promoted by both schools is to continuously cultivate excellent human resources who will lead the future global society.
Since signing a cooperation agreement for the establishment of a joint campus in June 2022, KAIST and NYU have been promoting campus sharing, joint research, and joint bachelor's degree programs. Including this, they are developing an innovative joint campus model and establishing an active international cooperation model.
In particular, the exchange student system for undergraduate students will be implemented starting from the second semester of the 2023 academic year. 30 students from KAIST and 11 students from NYU were selected through a competitive selection process and are participating. In the case of KAIST students, if they complete one of the six minor programs at NYU, they will receive a degree that states the completion of the minor upon graduation.
Based on the performance of the undergraduate exchange student operation, the two schools have also agreed to introduce a dual degree system for master's and doctoral students, and specific procedures are currently in progress.
In addition, from 2023 to the present, we are carrying out future joint research projects in 15 fields that are integrated with AI, and we plan to begin international joint research in 10 fields centered on AI and bio from the fourth quarter of this year.
NYU President Linda Mills said, “AI technology can play a significant role in addressing various social challenges such as climate change, health care, and education inequality,” and added that, “The global talent cultivated through our two schools will also go on to make innovative contributions to solving these social problems.”
Kwang-Hyung Lee, the president of KAIST, said, “In the era of competition for global hegemony in technology, the development of AI technology is an essential element for countries and companies to secure competitiveness,” and “Through long-term cooperation with NYU, we will take the lead in fostering world-class, advanced talents who can innovatively apply and develop AI in various fields.”
The signing ceremony held at the Four Seasons Hotel in Seoul was attended by KAIST officials including President Kwang-Hyung Lee, Hyun Deok Yeo, the Director of G-School, NYU officials including President Linda Mills, Kyunghyun Cho, a Professor of Computer Science and Data Science, and Dr. Karin Pavese, the Executive Director of NYU-KAIST Innovation Research Institute, amid attendance by other key figures from the industries situated in Korea. (End)
2024.09.10 View 4644 -
KAIST and Merck Sign MOU to Boost Biotech Innovation
< (From left) KAIST President Kwang-Hyung Lee and Merck CEO Matthias Heinzel >
KAIST (President Kwang-Hyung Lee) signed a Memorandum of Understanding (MOU) with Merck Life Science (CEO Matthias Heinzel) on May 29 to foster innovation and technology creation in advanced biotechnology.
Since May of last year, the two institutions have been discussing multidimensional innovation programs and will now focus on industry-academia cooperation to tackle bioindustry challenges with this MOU as a foundation.
KAIST will conduct joint research projects in various advanced biotechnology fields, such as synthetic biology, mRNA, cell line engineering, and organoids, using the chemical and biological portfolios provided by Merck.
Additionally, KAIST will establish an Experience Lab in collaboration with the Department of Materials Science and Engineering and the Graduate School of Medical Science and Engineering. This lab will support the discovery and analysis of candidate substances in materials science and biology.
Programs to enhance researchers' capabilities will also be offered. Scholarships for graduate students and awards for professors will be implemented. Researchers will have opportunities to participate in global academic events and educational programs hosted by Merck, such as the Curious 2024 Future Insight Conference and the Innovation Cup.
M Ventures, a venture capital subsidiary of Merck Group, will collaborate with KAIST's startup institute to support technology commercialization and continue to develop their startup ecosystem.
The signing ceremony at KAIST's main campus in Daejeon was attended by the CEO of Merck Life Science and the President of KAIST along with representatives from both institutions.
Matthias Heinzel, a member of the Executive Board of Merck and CEO Life Science, said, “This agreement with KAIST is a significant step toward accelerating the development of the life science industry both in Korea and globally. Advancing life science research and fostering the next generation of scientists is essential for discovering new medicines to meet global health needs.”
President Kwang-Hyung Lee responded, “We are pleased to share a vision for scientific advancement with Merck, a leading global technology company. We anticipate that this partnership will strengthen the connection between Merck’s life science business and the global scientific community.”
In March, Merck, a global science and technology company with over 350 years of history, announced a plan to invest 430 billion KRW (€300 million) to build a bioprocessing center in Daejeon, where KAIST is located. This is Merck's largest investment in the Asia-Pacific region.
2024.05.30 View 5746 -
World-renowned Soprano Sumi Jo and Broadcom CEO Hock Tan awarded honorary doctorate from KAIST
< (From left) Sumi Jo, Distinguished Visiting Professor at the Graduate School of Culture and Technology, and Broadcom President and CEO Hock Tan >
KAIST (President Kwang-Hyung Lee) announced that it awarded honorary doctorates to world-renowned soprano Sumi Jo, a distinguished visiting professor at the Graduate School of Culture and Technology, and the President and Chief Executive Officer of Broadcom Inc., Hock Tan, at the graduation ceremony held on the 16th of February, 2024.
Professor Sumi Jo, who received an honorary doctorate in science and technology, was appointed as a visiting professor at KAIST Graduate School of Culture and Technology in 2021 and established the "Sumi Jo Performing Arts Research Center" and have been involved in research providing valuable feedback on projects to put on stage performances utilizing AI-orchestrated musical ensemble technology and research on virtual voices using vocal synthesis technology, as well as participating in the demonstration of the technological performance showcased at KAIST. Also, she held a special lecture and a talk concert for KAIST students, sharing her experience as a celebrated soprano on the world stage and having honest conversations with students.
KAIST said, “The doctorate is being awarded in recognition of her contributions that is broadening the spectrum of research in the field of science and technology to lead the digital era by suggesting a direction for future
science and technology to take led by culture. Also, her significant contribution to promoting necessary internationalization capabilities helps KAIST as it is growing into a world-class university through new academic challenges.”
< Professor Sumi Jo (left), who received an honorary doctorate in science and technology, and President Kwang-Hyung Lee >
Professor Sumi Jo, who debuted as Gilda in the opera in 1986, has performed with world-class conductors such as Herbert von Karajan, Georg Solti, Zubin Mehta, and James Levine. She has released over 40 full-length albums and continues to excel in all areas of vocal performances, including film scores, songs, and musicals.
Professor Sumi Jo said, “When I received a proposal from President Kwang-Hyung Lee of KAIST to convey what I experienced and felt on the world stage to students of science at KAIST under the topic of ‘Music and My Life,’ questions started to swirl inside of me.”
She continued, “Singing on stage is about ‘expressing,’ and it is a comprehensive artistic process that unfolding the artist’s inner self (expression) and showing it (presentation) in a way that the audience can best feel it through
methods such as sound, lighting, and directing. And I realized that, I was singing all my life in an environment where science and technology coexisted with culture and art.”
“When I worked with the students here at KAIST, I came to realize that when scientific and technologically talented people are set free to really enjoy their ideas and explore them on their own terms, their insight become sharper and their creativity become richer,” she said. She went on to add, “I am proud to be able to join the graduates at the ceremony and would like to express my gratitude for awarding me the honorary doctorate.”
< (From left) President Hock Tan, who received the honorary doctorate in engineering, Mrs. Lya Trung Tan, and President Kwang-Hyung Lee >
Hock Tan received an honorary doctorate in engineering. He is a highly successful businessman who demonstrated entrepreneurship based on a profound understanding of science and technology, which transformed Broadcom into a global enterprise in technology that provides semiconductor and software solutions.
Broadcom has achieved advancement and technological innovation in the semiconductor industry tailored to computer and telecommunication networks, and is evaluated as having played a major role in bringing about the digital transformation movement that is now encompassing the global communities.
Tan attributes the secret to his success to ‘the considerate decision made by the university to award him the scholarship which enabled him to pursue his degree’ and ‘the great team members working with him’..’ Also, he is well-known as a person who considers giving back to society his most important mission.
To support effective medical treatment and identification of the cause of autism, Tan has made large donations to MIT and Harvard University since 2017 several times, and during the COVID-19 pandemic, he reinforced his support to improve the treatment of workers at community medical institutions and non-profit organizations. He also founded the Broadcom Foundation, which supports science, technology, engineering, and mathematics (STEM) education programs for students in and outside the United States.
KAIST said, “We are awarding CEO Hock Tan the honorary doctorate in recognition of his contribution to KAIST’s emergence as a world-class university, as he emphasized the importance of convergence research and
internationalization of KAIST during his time serving as an overseas member of the KAIST President's Advisory Council from 2006 to 2013, while providing policy advices built on his experiences of innovations from various parts around the world.”
Tan emphasized, “KAIST has been vital to Korea’s advancement in the global economy. (KAIST) remains a source of technological innovation,” and that, “It is truly an honor to be recognized by an institution with such a distinguished record of excellence in science, engineering and research.”
President Kwang-Hyung Lee said, “Professor Sumi Jo’s exploration into the future of performing arts through science and technology helps to expand KAIST’s scope and enhance our creative capabilities, while the dedication and humane efforts Hock Tan demonstrates as he contributes to digital innovation through corporate management and engages in various social contribution activities serves as a superb example to all members of KAIST.”
He continued, “These two have lived out the values of challenge and innovation and became examples for many, and we are very pleased to welcome them as the newest members of the KAIST family. On behalf of all members of KAIST, I deliver our sincere congratulations.”
2024.02.17 View 9713 -
2023 Global Startup Internship Seminar (GSIS)
The Center for Global Strategies and Planning at KAIST hosted the 2023 Global Startup Internship Seminar (GSIS) both online and offline from November 29th to December 1st.
Following the success of the 2022 Global Startup Internship Fair (GSIF), the 2023 KAIST GSIS was organized in an enhanced format. This event provided students with the opportunity to explore internship opportunities with U.S. startups. Six startups in the fields of AI, bio, digital healthcare, drones, and e-commerce, Imprimed, Soundable Health, Vessl AI, B Garage, UNEEKOR, and Bringko, all founded by KAIST alumni, were invited. More than 80 KAIST students registered in advance to participate in the event.
The participating companies in this seminar shared who they and what they do and provided career mentoring for KAIST students. Catherine Song, the CEO of Soundable Health and a KAIST alumna, said, "It is very meaningful to introduce our company to KAIST students and provide them with the opportunity to take part in global internships."
In addition to startup company information and mentoring sessions, the seminar included sessions on preparing CVs, cover letters, and business emails for U.S. internships, and how to settle in Silicon Valley. Internship experiences were also shared by current KAIST students. Finally, a J-1 visa information session was conducted, providing useful tips for students preparing for U.S. internships.
Man-Sung Yim, the Vice President of the International Office at KAIST, said, "We hope that KAIST students, who have nurtured a global entrepreneurial spirit through this event, will grow into aspiring entrepreneurs with confidence on the global stage." He also mentioned plans to leverage the success of this event by connecting it with other KAIST global entrepreneurship programs.
2023.12.05 View 5788 -
KAIST holds its first ‘KAIST Tech Fair’ in New York, USA
< Photo 1. 2023 KAIST Tech Fair in New York >
KAIST (President Kwang-Hyung Lee) announced on the 11th that it will hold the ‘2023 KAIST Tech Fair in New York’ at the Kimmel Center at New York University in Manhattan, USA, on the 22nd of this month. It is an event designed to be the starting point for KAIST to expand its startup ecosystem into the global stage, and it is to attract investments and secure global customers in New York by demonstrating the technological value of KAIST startup companies directly at location.
< Photo 2. President Kwang Hyung Lee at the 2023 KAIST Tech Fair in New York >
KAIST has been holding briefing sessions for technology transfer in Korea every year since 2018, and this year is the first time to hold a tech fair overseas for global companies.
KAIST Institute of Technology Value Creation (Director Sung-Yool Choi) has prepared for this event over the past six months with the Korea International Trade Association (hereinafter KITA, CEO Christopher Koo) to survey customer base and investment companies to conduct market analysis.
Among the companies founded with the technologies developed by the faculty and students of KAIST and their partners, 7 companies were selected to be matched with companies overseas that expressed interests in these technologies. Global multinational companies in the fields of IT, artificial intelligence, environment, logistics, distribution, and retail are participating as demand agencies and are testing the marketability of the start-up's technology as of September.
Daim Research, founded by Professor Young Jae Jang of the Department of Industrial and Systems Engineering, is a company specializing in smart factory automation solutions and is knocking on the door of the global market with a platform technology optimized for automated logistics systems.
< Photo 3. Presentation by Professor Young Jae Jang for DAIM Research >
It is a ‘collaborative intelligence’ solution that maximizes work productivity by having a number of robots used in industrial settings collaborate with one another. The strength of their solution is that logistics robots equipped with AI reinforced learning technology can respond to processes and environmental changes on their own, minimizing maintenance costs and the system can achieve excellent performance even with a small amount of data when it is combined with the digital twin technology the company has developed on its own.
A student startup, ‘Aniai’, is entering the US market, the home of hamburgers, with hamburger patty automation equipments and solutions. This is a robot kitchen startup founded by its CEO Gunpil Hwang, a graduate of KAIST’s School of Electrical Engineering which gathered together the experts in the fields of robot control, design, and artificial intelligence and cognitive technology to develop technology to automatically cook hamburger patties.
At the touch of a button, both sides of the patty are cooked simultaneously for consistent taste and quality according to the set condition. Since it can cook about 200 dishes in an hour, it is attracting attention as a technology that can not only solve manpower shortages but also accelerate the digital transformation of the restaurant industry.
Also, at the tech fair to be held at the Kimmel Center of New York University on the 22nd, the following startups who are currently under market verification in the U.S. will be participating: ▴'TheWaveTalk', which developed a water quality management system that can measure external substances and metal ions by transferring original technology from KAIST; ▴‘VIRNECT’, which helps workers improve their skills by remotely managing industrial sites using XR*; ▴‘Datumo’, a solution that helps process and analyze artificial intelligence big data, ▴‘VESSL AI’, the provider of a solution to eliminate the overhead** of machine learning systems; and ▴ ‘DolbomDream’, which developed an inflatable vest that helps the psychological stability of people with developmental disabilities.
* XR (eXtended Reality): Ultra-realistic technology that enhances immersion by utilizing augmented reality, virtual reality, and mixed reality technologies
** Overhead: Additional time required for stable processing of the program
In addition, two companies (Plasmapp and NotaAI) that are participating in the D-Unicorn program with the support of the Daejeon City and two companies (Enget and ILIAS Biologics) that are receiving support from the Scale Up Tips of the Ministry of SMEs and Startups, three companies (WiPowerOne, IDK Lab, and Artificial Photosynthesis Lab) that are continuing to realize the sustainable development goals for a total of 14 KAIST startups, will hold a corporate information session with about 100 invited guests from global companies and venture capital.
< Photo 4. Presentation for AP Lab >
Prior to this event, participating startups will be visiting the New York Economic Development Corporation and large law firms to receive advice on U.S. government support programs and on their attemps to enter the U.S. market. In addition, the participating companies plan to visit a startup support investment institution pursuing sustainable development goals and the Leslie eLab, New York University's one-stop startup support space, to lay the foundation for KAIST's leap forward in global technology commercialization.
< Photo 5. Sung-Yool Choi, the Director of KAIST Institute of Technology Value Creation (left) at the 2023 KAIST Tech Fair in New York with the key participants >
Sung-Yool Choi, the Director of KAIST Institute of Technology Value Creation, said, “KAIST prepared this event to realize its vision of being a leading university in creating global value.” He added, “We hope that our startups founded with KAIST technology would successfully completed market verification to be successful in securing global demands and in attracting investments for their endeavors.”
2023.09.11 View 15026 -
2023 Global Entrepreneurship Summer School in Silicon Valley Successfully Concluded
< 2023 Silicon Valley Global Entrepreneurship Summer School Participants >
The 2023 KAIST Global Entrepreneurship Summer School (GESS) was successfully held. Co-hosted by the Center for Global Strategies and Planning (GSP) (Director Man-Sung Yim) and the Startup KAIST (Director Hyeonmin Bae), the 2023 KAIST GESS was the second one of the summer programs, repeating the Silicon Valley global entrepreneurship bootcamp of 2022 (2022 GESC), based on industry-academia collaboration. This program was designed to provide students with the opportunity to visit Silicon Valley, the global hub of entrepreneurship, and personally experience the Silicon Valley culture while developing human networks that would serve as a foundation for their overseas startup development.
A total of 20 participants were selected earlier this year, including potential KAISTian entrepreneurs and early-stage entrepreneurs from KAIST within one year of incorporation. In particular, a number of foreign students of various nationalities such as Vietnam, Azerbaijan, Honduras, Indonesia, Philippines, and Kazakhstan, increased significantly, demonstrating the enthusiasm for entrepreneurship across national boundaries along with the program's growing international status. This year's event was also open to 20 Impact MBA and Social Entrepreneur (SE) students from KAIST's College of Business for the Silicon Valley program.
For the past two months, the participants have trained on business model development and pitching at KAIST's main campus in Daejeon. From June 21st to the 30th, they visited the campuses of leading universities, such as, Stanford University, UC Santa Cruz, and UC Berkeley, as well as KOTRA Silicon Valley Trade Center (Manager Hyoung il Kim), and local alumni companies and Apple company to experience the global technology startups. The start-ups by KAIST alums including B Garage (CEO Aiden Kim), ImpriMed (CEO Sungwon Lim), Medic Life Sciences (CEO Kyuho Han), and VESSL AI (CEO Jaeman Ahn) participated in the program and gave lectures and company tours to inspire the participants to have passion to take on the entrepreneurial endeavors and challenges.
On the last day, the participants gave presentations on their team’s business items in front of local venture capitalists in Silicon Valley. After receiving continuous coaching from Silicon Valley's professional accelerators through remote video conferencing and face-to-face mentoring for the last two months, the participants developed their business models and presented their creative and innovative ideas, revealing their potential as future global entrepreneurs. At the final competition, Team Sparky that developed “Snoove” won the first prize. Snoove is a scientifically-proven mattress accessory that applies mild vibration to the mattress to aid users in achieving better sleep, a method previously used to soothe infants.
< GESS Pitching Day Presentation >
Kevin Choi from the Team Sparky said, "Seeing and experiencing the realities of entrepreneurship in Silicon Valley, a global startup scene, made me think about the importance of unlearning, challenging, and failing to be a global entrepreneur who contributes to our society." Man-Sung Yim, the Associate Vice President of the International Office, who organized the event added, "Through this experience, we expect KAIST students to grow to become global leaders who would create global values and enhance the international reputation of our university."
Meanwhile, the GSP and Startup KAIST commented that they will to continue to develop the KAIST GESS program to foster prospective entrepreneurs who can compete in the global market based on the success of this program.
2023.07.05 View 10058 -
KAIST gearing up to train physician-scientists and BT Professionals joining hands with Boston-based organizations
KAIST (President Kwang Hyung Lee) announced on the 29th that it has signed MOUs with Massachusetts General Hospital, a founding member of the Mass General Brigham health care system and a world-class research-oriented hospital, and Moderna, a biotechnology company that developed a COVID-19 vaccine at the Langham Hotel in Boston, MA, USA on the morning of April 28th (local time). The signing ceremony was attended by officials from each institution joined by others headed by Minister LEE Young of the Korean Ministry of SMEs and Startups (MSS), and Commissioner LEE Insil of the Korean Intellectual Property Office.
< Photo 1. Photo from the Signing of MOU between KAIST-Harvard University Massachusetts General Hospital and KAIST-Moderna >
Mass General is the first and largest teaching hospital of Harvard Medical School in Boston, USA, and it is one of the most innovative hospitals in the world being the alma mater of more than 13 Nobel Prize winners and the home of the Mass General Research Institute, the world’s largest hospital-based research program that utilizes an annual research budget of more than $1.3 billion.
KAIST signed a general agreement to explore research and academic exchange with Mass General in September of last year and this MOU is a part of its follow-ups.
Mass General works with Harvard and the Massachusetts Institute of Technology (MIT), as well as local hospitals, to support students learn the theories of medicine and engineering, and gain rich clinical research experience.
Through this MOU, KAIST will explore cooperation with an innovative ecosystem created through the convergence of medicine and engineering. In particular, KAIST’s goal is to develop a Korean-style training program and implement a differentiated educational program when establishing the science and technology-oriented medical school in the future by further strengthening the science and engineering part of the training including a curriculum on artificial intelligence (AI) and the likes there of.
Also, in order to foster innovative physician-scientists, KAIST plans to pursue cooperation to develop programs for exchange of academic and human resources including programs for student and research exchanges and a program for students of the science and technology-oriented medical school at KAIST to have a chance to take part in practical training at Mass General.
David F.M. Brown, MD, Mass General President, said, “The collaboration with KAIST has a wide range of potentials, including advice on training of physician-scientists, academic and human resource exchanges, and vitalization of joint research by faculty from both institutions. Through this agreement, we will be able to actively contribute to global cooperation and achieve mutual goals.”
Meanwhile, an MOU between KAIST and Moderna was also held on the same day. Its main focus is to foster medical experts in cooperation with KAIST Graduate School of Medical Science and Engineering (GSMSE), and plans to cooperate in various ways in the future, including collaborating for development of vaccine and new drugs, virus research, joint mRNA research, and facilitation of technology commercialization.
In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA) to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities. The Company has 48 programs in development across 45 development candidates, of which 38 are currently in active clinical trials.
“We are grateful to have laid a foundation for collaboration to foster industry experts with the Korea Advanced Institute of Science and Technology, a leader of science and technology innovation in Korea,” said Arpa Garay, Chief Commercial Officer, Moderna. “Based on our leadership and expertise in developing innovative mRNA vaccines and therapeutics, we hope to contribute to educating and collaborating with professionals in the bio-health field of Korea.“
President Kwang Hyung Lee of KAIST, said, “We deem this occasion to be of grave significance to be able to work closely with Massachusetts General Hospital, one of the world's best research-oriented hospitals, and Moderna, one of the most influential biomedical companies.”
President Lee continued, "On the basis of the collaboration with the two institutions, we will be able to bring up qualified physician-scientists and global leaders of the biomedical business who will solve problems of human health and their progress will in turn, accelerate the national R&D efforts in general and diversify the industry."
2023.04.29 View 13726